Published in Clin Immunol Immunopathol on April 01, 1974
A characterization of human tonsillar lymphocytes after separation from other tonsillar cells in an isokinetic gradient of ficoll in tissue culture medium. Am J Pathol (1976) 0.94
Lymphocyte subpopulations. Human red blood cell rosettes. Clin Exp Immunol (1975) 0.93
Inhibitory effect of sheep erythrocyte fragments on rosette formation of human T lymphocytes with sheep red blood cells. Clin Exp Immunol (1976) 0.79
Immunoglobulin levels of tonsillar cells. Arch Otorhinolaryngol (1979) 0.75
Immunoperoxidase detection of T and B cells in blood compared with conventional methods. J Clin Pathol (1984) 0.75
Polymyositis and dermatomyositis (first of two parts). N Engl J Med (1975) 18.52
Polymyositis and dermatomyositis (second of two parts). N Engl J Med (1975) 7.26
Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) (1977) 4.79
Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells. J Exp Med (1979) 3.76
Metabolic profiles of three fiber types of skeletal muscle in guinea pigs and rabbits. Biochemistry (1972) 3.69
HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet (1993) 3.39
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci (2001) 3.11
Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest (1974) 2.96
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A (1980) 2.88
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med (1980) 2.76
Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis (2001) 2.51
Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum (1981) 2.30
Quality of care for patients with rheumatoid arthritis. JAMA (2000) 2.30
Histochemical, biochemical, and contractile properties of red, white, and intermediate fibers. Am J Physiol (1971) 2.08
Minocycline treatment of rheumatoid arthritis. Ann Intern Med (1995) 2.04
Erosive osteoarthritis of the hands. Arthritis Rheum (1966) 1.98
The nature of the stimulatory cell in human allogeneic and autologous MLC reactions; role of isolated IgM-bearing B cells. J Immunol (1979) 1.96
Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol (2001) 1.93
Tinnitus as an indication of therapeutic serum salicylate levels. JAMA (1973) 1.92
Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med (1988) 1.87
Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum (1978) 1.83
Stereological analysis of mammalian skeletal muscle. I. Soleus muscle of the adult guinea pig. J Cell Biol (1974) 1.81
Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum (1989) 1.80
Pulse methylprednisolone in rheumatoid arthritis: a double-blind cross-over trial. Ann Intern Med (1981) 1.79
Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Arthritis Rheum (2007) 1.77
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration. Ann Rheum Dis (1984) 1.76
Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol (2000) 1.67
Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum (1977) 1.62
Cellular immunological aspects of rheumatoid arthritis. Semin Arthritis Rheum (1974) 1.61
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med (1993) 1.61
Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (1980) 1.56
Aortic insufficiency in five patients with Reiter's syndrome. A detailed clinical and pathologic study. Am J Med (1972) 1.53
The effect of aspirin on serum indomethacin. Clin Pharmacol Ther (1972) 1.52
Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients. Arthritis Rheum (1993) 1.52
Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Ann Rheum Dis (1972) 1.52
EIA for detection of Rochalimaea henselae-reactive IgG, IgM, and IgA antibodies in patients with suspected cat-scratch disease. J Infect Dis (1993) 1.48
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
Two types of Ia-positive T cells. Synthesis and exchange of Ia antigens. J Exp Med (1980) 1.47
HLA-B27 does not affect invasion of arthritogenic bacteria into human cells. J Rheumatol (1998) 1.43
The role of the lymphocyte and its products in the propagation of joint disease. Ann N Y Acad Sci (1975) 1.41
Lymphocyte abnormalities in ankylosing spondylitis. Ann Rheum Dis (1977) 1.39
Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med (1979) 1.39
Experimental allergic myositis in rats. Arthritis Rheum (1971) 1.38
Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis. J Clin Invest (1978) 1.37
Laboratory tests in clinical immunology: a critique. Am J Med (1980) 1.34
Effect of corticosteroids on the human immune response: comparison of one and three daily 1 gm intravenous pulses of methylprednisolone. J Lab Clin Med (1978) 1.32
A study of 20 SLE patients with intravenous immunoglobulin--clinical and serologic response. Lupus (1999) 1.31
Effect of exercise on skeletal muscle. I. Biochemical and histochemical properties. J Appl Physiol (1970) 1.30
Variations of serum concentrations and half-life of salicylate in patients with rheumatoid arthritis. Arthritis Rheum (1971) 1.28
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis. Arthritis Rheum (1995) 1.28
Possible role of Rochalimaea henselae in pathogenesis of AIDS encephalopathy. Lancet (1992) 1.26
Lymphocyte populations: separation by discontinuous density gradient centrifugation. J Immunol (1973) 1.26
Helper factors derived from autologous mixed lymphocyte cultures. Cell Immunol (1980) 1.26
A case report: thoracic duct lymphocyte drainage in rheumatoid arthritis. Clin Immunol Immunopathol (1973) 1.25
Correlates of acute renal failure in patients receiving parenteral amphotericin B. Kidney Int (2001) 1.23
Placental transfer of immunoglobulin G subclasses. Clin Diagn Lab Immunol (1994) 1.23
Simultaneous pharmacokinetics of indomethacin in serum and synovial fluid. Ann Rheum Dis (1973) 1.21
Inhibition by gold of human lymphocyte stimulation. An in vitro study. Ann Rheum Dis (1977) 1.21
Skeletal muscle. Basic and clinical aspects and illustrative new diseases. Ann Intern Med (1967) 1.20
Osteoarthritis of the metacarpophalangeal joint: hook-like osteophytes. Arthritis Rheum (1969) 1.19
Human lymphocyte subpopulation: early and late rosettes. J Immunol (1975) 1.18
Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria. Clin Exp Immunol (1985) 1.18
HLA-B27 modulates intracellular survival of Salmonella enteritidis in human monocytic cells. Eur J Immunol (1997) 1.18
The joint alignment and motion scale: a simple measure of joint deformity in patients with rheumatoid arthritis. J Rheumatol (1987) 1.14
Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. I. pharmacology, clinical history, administration, side effects, and safety. Obstet Gynecol (1980) 1.13
Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus. Arthritis Rheum (1978) 1.13
What are we measuring? An examination of self-reported functional status measures. Arthritis Rheum (1988) 1.12
Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun (1987) 1.12
Study of Reiter's syndrome, with special emphasis on Yersinia enterocolitica. Immunol Rev (1985) 1.11
Characteristics of a cytotoxin ("lymphotoxin") produced by stimulation of human lymphoid tissue. J Immunol (1973) 1.11
Human lymphocyte subpopulations effect of epinephrine. Clin Exp Immunol (1976) 1.10
Response of muscle glycogen and phosphorylase to electrical stimulation in trained and nontrained guinea pigs. Exp Neurol (1970) 1.10
Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum (1983) 1.10
Management of rheumatoid arthritis: the historical context. J Rheumatol (2001) 1.09
Non-steroidal and analgesic therapy in the elderly. Clin Rheum Dis (1986) 1.09
Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus. Arthritis Rheum (1994) 1.09
Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides. J Clin Microbiol (2001) 1.07
A Yersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J Immunol (1987) 1.07
In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter's syndrome. Lack of response in other HLA-B27 positive individuals. Arthritis Rheum (1984) 1.07
Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma). J Am Dent Assoc (1977) 1.07
Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum (1974) 1.07
Anticardiolipin antibodies in systemic sclerosis. Arthritis Rheum (1986) 1.07
Pathogenesis of fructose hepatotoxicity. Lab Invest (1974) 1.06
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer (1983) 1.05
ACR remission criteria and response criteria. Clin Exp Rheumatol (2006) 1.05
Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect. Clin Immunol Immunopathol (1981) 1.04
Effects of cyclophosphamide on B- and T-lymphocytes in rheumatoid arthritis. Arthritis Rheum (1974) 1.04
Immunological studies in familial primary biliary cirrhosis. Gastroenterology (1976) 1.04
Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome. J Infect Dis (1995) 1.03
Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med (1978) 1.03
Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol (1988) 1.03